Accordingly, in APP-overexpressing transgenic mouse models of amyloidosis, the mutant APP is either the human transgene or a chimeric mo/huAPP transgene bearing humanized Aβ domain with single or multiple fAD-associated mutations [17]. Here, APP is linked to amyloidosis.